From: Circulating bile acids predict outcome in critically ill patients
Parameter | Cardiogenic shock | Septic shock | Post-surgery | Others |
---|---|---|---|---|
n (%) | 146 (46) | 43 (13) | 56 (18) | 75 (23) |
Female (%) | 50 (34) | 18 (42) | 33 (39) | 27 (36) |
Age (years) | 66 (57–73) | 64 (60–73) | 69 (56–77) | 62 (52–76) |
APACHE2 | 25 (17–34) | 28 (21–36) | 15 (10–19) | 16 (12–26) |
SAPS2 | 56 (41–77) | 62 (44–74) | 38 (27–51) | 37 (27–53) |
Vasopressor (%)c, e, f | 146 (100) | 43 (100) | 53 (95) | 31 (41) |
Mechanical ventilation (%)b, c, d, e, f | 92 (63) | 26 (61) | 47 (84) | 23 (31) |
RRT (%)b, c, d | 34 (25) | 10 (25) | 3 (6) | 6 (10) |
28-day mortality (%)b, c, d, e | 30 (21) | 11 (26) | 2 (4) | 3 (4) |
Serum laboratory parameters | ||||
CRP (mg/dl)a, b, d, e, f | 5 (1.5–8.3) | 11.4 (4.5–24.1) | 2 (0.6–5) | 5 (2–8.3) |
Creatinine (mg/dl)b, c, d, e | 1.4 (0.9–2) | 1.7 (1.1–3.4) | 1 (0.8–1.2) | 1.1 (0.9–1.6) |
WBC (G/l)a, e, f | 10.3 (7.6–13) | 11.9 (8.5–19.6) | 11.3 (8.8–15) | 9.1 (7.5–11.8) |
Fibrinogen (mg/dl)a, b, d, e, f | 418 (318–529) | 489 (417–647) | 277 (216–387) | 392 (246–479) |
AST (U/l)c | 58 (30–153) | 41 (26–84) | 50 (32–69) | 30 (20–58) |
Bilirubin (mg/dl)b, c, d, e | 0.8 (0.5–1.2) | 0.8 (0.6–1.3) | 0.6 (0.5–0.8) | 0.6 (0.5–0.9) |